Ryan Charles Drexler - 13 Aug 2020 Form 4 Insider Report for MusclePharm Corp

Role
CEO, Director, 10%+ Owner
Signature
/s/ Ryan Charles Drexler
Issuer symbol
N/A
Transactions as of
13 Aug 2020
Net transactions value
+$2,457,549
Form type
4
Filing time
17 Aug 2021, 21:56:11 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MSLP Convertible Promissory Note Other $2,457,549 $2,457,549 13 Aug 2021 Common Stock Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 15, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,457,549 with the Company. (the "October 2020 Convertible Note"). Both the principal and any accrued but unpaid interest under the October 2020 Convertible Note will become due and payable on July 14, 2022, unless earlier converted or repaid.
F2 Closing price on October 15, 2021
F3 Determined on October 15, 2021